Showing 19,861 - 19,880 results of 19,930 for search '(( 50 ((ng decrease) OR (teer decrease)) ) OR ( 100 ((mean decrease) OR (a decrease)) ))', query time: 0.87s Refine Results
  1. 19861

    Top 10 reasons for visits in 2019. by Karen Tu (39526)

    Published 2024
    “…Most INTRePID countries experienced a decline in monthly visit rates during the first year of the pandemic, with rate ratios (RR) and 95% confidence intervals (CI) ranging from RR:0.57 (95%CI:0.49–0.66) to RR:0.90 (95%CI:0.83–0.98), except for in Canada (RR:0.99, 95%CI:0.94–1.05) and Norway (RR:1.00, 95%CI:0.92–1.10), where rates remained stable and in Australia where rates increased (RR:1.19, 95%CI:1.11–1.28). …”
  2. 19862

    Top 10 reasons for in-person visits in 2020. by Karen Tu (39526)

    Published 2024
    “…Most INTRePID countries experienced a decline in monthly visit rates during the first year of the pandemic, with rate ratios (RR) and 95% confidence intervals (CI) ranging from RR:0.57 (95%CI:0.49–0.66) to RR:0.90 (95%CI:0.83–0.98), except for in Canada (RR:0.99, 95%CI:0.94–1.05) and Norway (RR:1.00, 95%CI:0.92–1.10), where rates remained stable and in Australia where rates increased (RR:1.19, 95%CI:1.11–1.28). …”
  3. 19863

    PAK inhibition induces apoptosis via BAD and blocks the progression of BRAF mutant melanomas. by Rolando Ruiz (4285165)

    Published 2017
    “…<p>(A) FRAX597 inhibits PAK1 activation and induces apoptosis in BRAF<sup>V600E</sup> melanoma cell lines. …”
  4. 19864

    Top 10 reasons for virtual visits in 2020. by Karen Tu (39526)

    Published 2024
    “…Most INTRePID countries experienced a decline in monthly visit rates during the first year of the pandemic, with rate ratios (RR) and 95% confidence intervals (CI) ranging from RR:0.57 (95%CI:0.49–0.66) to RR:0.90 (95%CI:0.83–0.98), except for in Canada (RR:0.99, 95%CI:0.94–1.05) and Norway (RR:1.00, 95%CI:0.92–1.10), where rates remained stable and in Australia where rates increased (RR:1.19, 95%CI:1.11–1.28). …”
  5. 19865

    Photoluminescent and Slow Magnetic Relaxation Studies on Lanthanide(III)-2,5-pyrazinedicarboxylate Frameworks by Maria Vanda Marinho (2724424)

    Published 2017
    “…In these compounds, τ<sup>–1</sup> decreases with decreasing temperature at any magnetic field, but no Arrhenius law can simulate such a dependence in all the temperature range. …”
  6. 19866

    Photoluminescent and Slow Magnetic Relaxation Studies on Lanthanide(III)-2,5-pyrazinedicarboxylate Frameworks by Maria Vanda Marinho (2724424)

    Published 2017
    “…In these compounds, τ<sup>–1</sup> decreases with decreasing temperature at any magnetic field, but no Arrhenius law can simulate such a dependence in all the temperature range. …”
  7. 19867

    Photoluminescent and Slow Magnetic Relaxation Studies on Lanthanide(III)-2,5-pyrazinedicarboxylate Frameworks by Maria Vanda Marinho (2724424)

    Published 2017
    “…In these compounds, τ<sup>–1</sup> decreases with decreasing temperature at any magnetic field, but no Arrhenius law can simulate such a dependence in all the temperature range. …”
  8. 19868

    Photoluminescent and Slow Magnetic Relaxation Studies on Lanthanide(III)-2,5-pyrazinedicarboxylate Frameworks by Maria Vanda Marinho (2724424)

    Published 2017
    “…In these compounds, τ<sup>–1</sup> decreases with decreasing temperature at any magnetic field, but no Arrhenius law can simulate such a dependence in all the temperature range. …”
  9. 19869

    Photoluminescent and Slow Magnetic Relaxation Studies on Lanthanide(III)-2,5-pyrazinedicarboxylate Frameworks by Maria Vanda Marinho (2724424)

    Published 2017
    “…In these compounds, τ<sup>–1</sup> decreases with decreasing temperature at any magnetic field, but no Arrhenius law can simulate such a dependence in all the temperature range. …”
  10. 19870

    Differential distribution of V2b interneuron subdivisions along the rostrocaudal axis of the spinal cord. by Cédric Francius (443799)

    Published 2013
    “…(N–N″) At thoracic levels, the amount of V2b neurons that are MafA<sup>+</sup> (magenta) is decreased (right arrowhead) compared to brachial levels. …”
  11. 19871

    SRMS accelerates ubiquitination of FKBP51 under nutrient-replete condition. by Jung Mi Park (5204840)

    Published 2021
    “…<p>(<b>A</b>) SRMS promotes accumulation of cytosolic p-AKT(S473) in a kinase-dependent manner. …”
  12. 19872

    Delayed onset to puberty and ocular, endocrine, haematological, and plasma abnormalities. by Rebecca E. McIntyre (119172)

    Published 2012
    “…<p>A. Periodic acid-Schiff (PAS) staining and cleaved (activated) caspase-3 immunostaining of adrenal sections from 16 week-old virgin female <i>Cenpj<sup>tm/tm</sup></i> mice (n = 3) confirmed corticomedullary pigmentation and ongoing apoptosis in the X-zone, respectively (representative images, scale bars 100 µm). …”
  13. 19873

    Dorsal-ventral asymmetry of endothelial cell morphology based on more detailed classification. by Daniel Seeler (6451463)

    Published 2024
    “…In Endoglin-deficient embryos, D-LRs had a 16%/6.8% higher median compactness at 48 hpf/72 hpf, respectively. …”
  14. 19874

    Pyrimidine synthesis and transport is very sensitive to mis-regulation. by Indu Warrier (581139)

    Published 2024
    “…<b>(E)</b> Adding additional uracil to the medium (from 20 ug/mL to 100 ug/mL) does not alter the uracil independent growth defect observed for SP_0701_mOFF (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011188#pgen.1011188.s003" target="_blank">S3 Table</a>). …”
  15. 19875

    Image_2_CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.jpeg by Chris David Lauruschkat (15443078)

    Published 2023
    “…Recently, antiviral letermovir prophylaxis during the first 100 days after alloSCT replaced PCR-guided preemptive therapy as the primary standard of care for HCMV reactivations. …”
  16. 19876

    Image_1_Effects of 1,25-Dihydroxyvitamin D3 and 25-Hydroxyvitamin D3 on PBMCs From Dairy Cattle Naturally Infected With Mycobacterium avium subsp. paratuberculosis.pdf by Taylor L. T. Wherry (10022300)

    Published 2022
    “…Briefly, PBMCs were isolated and cultured in vitro with 4 ng/ml 1,25-dihydroxyvitamin D<sub>3</sub> [1,25(OH)<sub>2</sub>D<sub>3</sub>] or 100 ng/ml 25(OH)D<sub>3</sub>. Treatment with 1,25(OH)<sub>2</sub>D<sub>3</sub> resulted in decreased secretion for some pro-inflammatory cytokines in clinical animals, including IL-1β, IL-6, and IFN-γ. …”
  17. 19877

    Direct Unequal Cleavages: Embryo Developmental Competence, Genetic Constitution and Clinical Outcome by Qiansheng Zhan (3374120)

    Published 2016
    “…<div><p>Objective</p><p>To investigate the prevalence, developmental potential, chromosomal constitution and clinical outcome of embryos with direct unequal cleavages (DUC).</p><p>Design</p><p>A retrospective observational study.</p><p>Setting</p><p>Academic Institution.…”
  18. 19878

    Image_4_CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.jpeg by Chris David Lauruschkat (15443078)

    Published 2023
    “…Recently, antiviral letermovir prophylaxis during the first 100 days after alloSCT replaced PCR-guided preemptive therapy as the primary standard of care for HCMV reactivations. …”
  19. 19879

    Table_1_CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis.pdf by Chris David Lauruschkat (15443078)

    Published 2023
    “…Recently, antiviral letermovir prophylaxis during the first 100 days after alloSCT replaced PCR-guided preemptive therapy as the primary standard of care for HCMV reactivations. …”
  20. 19880

    Data_Sheet_1_Effects of 1,25-Dihydroxyvitamin D3 and 25-Hydroxyvitamin D3 on PBMCs From Dairy Cattle Naturally Infected With Mycobacterium avium subsp. paratuberculosis.xlsx by Taylor L. T. Wherry (10022300)

    Published 2022
    “…Briefly, PBMCs were isolated and cultured in vitro with 4 ng/ml 1,25-dihydroxyvitamin D<sub>3</sub> [1,25(OH)<sub>2</sub>D<sub>3</sub>] or 100 ng/ml 25(OH)D<sub>3</sub>. Treatment with 1,25(OH)<sub>2</sub>D<sub>3</sub> resulted in decreased secretion for some pro-inflammatory cytokines in clinical animals, including IL-1β, IL-6, and IFN-γ. …”